Ultragenyx Reports Preliminary 2023 Revenue; Guidance for
From GlobeNewswire: Ultragenyx Pharmaceutical Inc. reported 2023 total revenue of $430 million to $435 million, Crysvita® revenue of $325 million
From GlobeNewswire: Ultragenyx Pharmaceutical Inc. reported 2023 total revenue of $430 million to $435 million, Crysvita® revenue of $325 million
From Nasdaq: Investors were taken by surprise with three consecutive down days to start the year, but the stronger-than-expected December
From GlobeNewswire: Weatherford International plc will host a conference call on February 7, 2024, to discuss its results for the
From GlobeNewswire: USCB Financial Holdings, Inc. will report financial results after the market closes on Thursday, January 25, 2024. A
From GlobeNewswire: Matthews International Corporation plans to release its first quarter fiscal year 2024 earnings results after the market closes
From GlobeNewswire: Park Hotels & Resorts Inc. (NYSE: PK) plans to report financial results for Q4 and full year 2023
From GlobeNewswire: First Hawaiian, Inc. announces the release of its fourth-quarter 2023 financial results on January 26, 2024. The company
From Nasdaq: In 2023, markets saw positive returns, with Nasdaq up 45%, S&P 500 rose 26%, and US Treasuries gained
From GlobeNewswire: Surgery Partners, Inc. CEO and CFO will be presenting at the J.P. Morgan Healthcare Conference on January 8,
From GlobeNewswire: OceanFirst Financial Corp. will be releasing its earnings report for the quarter ending December 31, 2023, on January
From GlobeNewswire: Capital Link is hosting a series of Corporate Presentations by leading maritime companies presenting their business development, strategy,
From Nasdaq: 1) The global markets and economy roundup from Nasdaq’s IR team reveals the mixed performance of equities, with
From GlobeNewswire: On January 23, 2024, CN (TSX: CNR) (NYSE: CNI) will release its financial and operational results for the
From GlobeNewswire: CN (TSX: CNR) (NYSE: CNI) will release its Q4 and full-year 2023 financial results on January 23, 2024,
From GlobeNewswire: First Western Financial, Inc. will release its fourth-quarter financial results on January 25, 2024. A conference call will
From GlobeNewswire: SCYNEXIS, Inc. has announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247 for
From GlobeNewswire: Axial Therapeutics, a biotechnology company, will feature its CEO Dr. A. Stewart Campbell at the 2024 Biotech Showcase.
From RTT News: Constellation Brands, Inc. has maintained its comparable earnings guidance for fiscal 2024 in its third-quarter financial results.
From GlobeNewswire: Mersana Therapeutics, Inc. (NASDAQ: MRSN) is currently enrolling patients in dose escalation and backfill cohorts for phase 1
From GlobeNewswire: Asure Software, Inc. is set to attend the 26th Annual Needham Growth Conference on January 18, 2024 in
From GlobeNewswire: DZS has obtained $25 million in funding and signed an agreement to sell its Asia operations for $48
From GlobeNewswire: Silicon Motion Technology Corporation is expecting sequential revenue growth to exceed the high-end of its guidance range of
From GlobeNewswire: CervoMed Inc. (NASDAQ: CRVO) will provide a corporate update at the Emerging Growth Conference 66 on January 11th,
From GlobeNewswire: Allegro MicroSystems, Inc. will present at Needham’s 26th Annual Growth Conference on January 19, 2024, with a live
From Nasdaq: Asia-Pacific equity markets finished lower except for India’s SENSEX and Japan’s Nikkei, which gained after Yen weakness boosted